EP. 12: OAB Patient Monitoring and Followup Considerations in the Third-Line Treatment Setting

News
Video

An overview of patient monitoring strategies experts use to establish individualized followup with patients receiving therapy for OAB in the third-line setting.

Please see full Prescribing Information for onabotulinumtoxinA, including Boxed Warning.

Sponsored by AbbVie US Medical Affairs

This content is intended for US/PR Healthcare Professionals.

The Medical Affairs department of AbbVie Inc. is the sole author and copyright owner of this presentation and has paid Urology Times to host this presentation. AbbVie is solely responsible for all written and oral content within this presentation. © 2023 AbbVie Inc. All rights reserved.

Related Videos
Leslie Rickey, MD, MPH, answers a question during a video interview
A panel of 3 experts on overactive bladder
A panel of 3 experts on overactive bladder
A panel of 3 experts on overactive bladder
A panel of 3 experts on overactive bladder
A panel of 3 experts on overactive bladder
Doctor consulting patient | Image Credit: © Liudmila Dutko -stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
stethoscope on laptop keyboard
© 2024 MJH Life Sciences

All rights reserved.